HealthCare Global Enterprises (HCG) announced its financial results for the second quarter and first half of fiscal year 2027 (Q2 FY27). The company reported a 16% year-on-year growth in revenue, reaching INR 7,318 million. Adjusted EBITDA also saw a substantial increase of 17% year-on-year, reaching INR 1,425 million, with margins improving to 19.7%.
HCG Reports Strong Q2 FY27 Financial Performance
HealthCare Global Enterprises Limited (HCG) has disclosed its financial highlights for the quarter and six months ended September 30, 2026. The company demonstrated robust growth, with revenue increasing by 16% year-on-year to INR 7,318 million for Q2 FY27. This growth was attributed to broad-based performance across its clusters, driven by a 9% volume growth and a 7% increase in ARPP.
Key Financial Metrics
Adjusted EBITDA for Q2 FY27 grew by an impressive 17% year-on-year to INR 1,425 million. The Adjusted EBITDA margin improved to 19.7%, up from 19.2% in the prior year, reflecting enhanced revenue quality. Operational EBITDA stood at INR 1,364 million.
Operational and Business Developments
HCG also highlighted key business developments, including the addition of 25 operational beds in Q2 FY27, contributing to a total of 146 bed additions in H1 FY27. The company operationalized advanced technology, such as the MR-LINAC system at North Bengaluru, and introduced new clinical programs including CAR-T cell therapy and robotic surgeries. The company’s international business revenue grew significantly by 54% year-on-year.
Regional Performance
The South region reported an 18% revenue growth to INR 2,941 million, driven by ARPP growth. The West region saw a 10% revenue growth to INR 3,147 million, led by volume growth. The East region experienced a strong 23% revenue growth to INR 928 million.
Balance Sheet and Debt Position
As of September 30, 2026, the Net Debt stood at INR 5,751 million, with cash and cash equivalents at INR 1,296 million. The company incurred capital expenditure of INR 1,279 million in H1 FY27, primarily towards expansion and upgrades.
Strategic Priorities
HCG’s strategic priorities include optimizing its existing network, improving network efficiency, investing in growth through brownfield expansion, and enhancing patient experience. The company aims for significant bed additions by FY30, driven by brownfield expansion. The leadership team has been strengthened, and operational excellence initiatives are underway.
Source: BSE
